Ronald Hoffman, MD
Icahn School of Medicine at Mount Sinai · Mt. Sinai · New York Eye and Ear
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ronald Hoffman, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:46 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04281498 · Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 MutationJohn Mascarenhas · completed · Accelerated/Blast-phase Myeloproliferative Neoplasm, Chronic-phase Myelofibrosis, IDH2 Mutation · study chair
- Ph1NCT03895112 · MPN-RC 118 AVID200 in MyelofibrosisJohn Mascarenhas · completed · Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis · study director
- Ph1NCT02407080 · Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential ThrombocythemiaJohn Mascarenhas · completed · Polycythemia Vera, Essential Thrombocythemia · study chair
- Ph1/Ph2NCT02076191 · Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AMLJohn Mascarenhas · completed · Myeloproliferative Neoplasms · principal investigator
- N/ANCT01970930 · Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) PatientsIcahn School of Medicine at Mount Sinai · completed · Polycythemia Vera, Essential Thrombocythemia · principal investigator
- Ph1/Ph2NCT01298934 · LBH589 (Panobinostat) for the Treatment of MyelofibrosisRonald Hoffman · unknown · Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Post-Essential Thrombocythemia Related Myelofibrosis · principal investigator
- Ph1NCT01291784 · Anti-TGF-beta Therapy in Patients With MyelofibrosisJohn Mascarenhas · terminated · Myelofibrosis, Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase · study chair
- Ph3NCT01259856 · Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Ronald Hoffman · completed · High Risk Polycythemia Vera, High Risk Essential Thrombocythemia · study chair
- Ph2NCT00940784 · Clopidogrel and Aspirin for the Treatment of Polycythemia VeraRonald Hoffman · withdrawn · Polycythemia Vera · principal investigator
- Ph1NCT00910728 · Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative DiseasesAstraZeneca · completed · Primary Myelofibrosis (PMF), Post-Polycythaemia Vera, Essential Thrombocythaemia Myelofibrosis · principal investigator
- N/ANCT00747435 · Safety and Effectiveness of the MED-EL Electric-Acoustic SystemMed-El Corporation · completed · Hearing Loss · principal investigator
- Ph1/Ph2NCT00668421 · CEP-701 (Lestaurtinib) in MyelofibrosisRonald Hoffman · unknown · Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera · principal investigator
- Ph2NCT00667277 · Phase II Study of Bevacizumab (Avastin®) in MyelofibrosisRonald Hoffman · terminated · Myelofibrosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 3: Development of Strategies to Deplete Myelofibrosis Stem CellsP01CA108671 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ronald Hoffman · fiscal years 2006 to 2026
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.